|
[1]
|
Boriani, G., Tartaglia, E., Trapanese, P., Tritto, F., Gerra, L., Bonini, N., et al. (2025) Subclinical Atrial Fibrillation/Atrial High-Rate Episodes: What Significance and Decision-Making? European Heart Journal Supplements, 27, i162-i166. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Boriani, G., Gerra, L., Mei, D.A., Bonini, N., Vitolo, M., Proietti, M., et al. (2024) Detection of Subclinical Atrial Fibrillation with Cardiac Implanted Electronic Devices: What Decision Making on Anticoagulation after the NOAH and Artesia Trials? European Journal of Internal Medicine, 123, 37-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Pradhan, A., Shah, S., Vishwakarma, P. and Singh, A.K. (2026) Subclinical Atrial Fibrillation: Implications of Recent Trials for Guideline Updates? World Journal of Cardiology, 18, Article ID: 111882. [Google Scholar] [CrossRef]
|
|
[4]
|
Kerr, B. and Brandon, L. (2022) Atrial Fibrillation, Thromboembolic Risk, and the Potential Role of the Natriuretic Peptides, a Focus on BNP and NT-proBNP—A Narrative Review. IJC Heart & Vasculature, 43, Article ID: 101132. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Aksan, G., Yanık, A., Yontar, O.C., Gedikli, Ö., Arslan, U. and Soylu, K. (2021) Galectin-3 Levels and the Prediction of Atrial High-Rate Episodes in Patients with Cardiac Resynchronization Therapy. Journal of Investigative Medicine, 69, 20-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Liao, M., Chen, C., Lin, T., Cheng, L., Ting, H. and Liu, Y. (2020) High-Sensitivity C-Reactive Protein Is a Predictor of Subsequent Atrial High-Rate Episodes in Patients with Pacemakers and Preserved Ejection Fraction. Journal of Clinical Medicine, 9, Article 3677. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Chen, Y., Wang, H., Lin, P., Chuang, J. and Yang, M. (2021) Macrophage Inflammatory Protein-1 Alpha, a Potential Biomarker for Predicting Left Atrial Remodeling in Patients with Atrial Fibrillation. Frontiers in Cardiovascular Medicine, 8, Article 754792. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
McIntyre, W.F., Benz, A.P., Becher, N., Healey, J.S., Granger, C.B., Rivard, L., et al. (2024) Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and Artesia Trials. Circulation, 149, 981-988. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Simu, G., Rosu, R., Cismaru, G., Puiu, M., Gusetu, G., Minciuna, I., et al. (2021) Atrial High-Rate Episodes: A Comprehensive Review. Cardiovascular Journal of Africa, 32, 48-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Van Gelder, I.C., Rienstra, M., Bunting, K.V., Casado-Arroyo, R., Caso, V., Crijns, H.J.G.M., et al. (2024) 2024 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTs). European Heart Journal, 45, 3314-3414. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Boriani, G., Imberti, J.F., Bonini, N., Albini, A., Autieri, A. and Vitolo, M. (2020) Episodi aritmici ad elevata frequenza atriale: significato clinico, impatto prognostico e gestione clinica. Giornale Italiano di Cardiologia, 21, 779-789. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Spartalis, M., Kontogiannis, C., Spartalis, E., Iliopoulos, D.C. and Siasos, G. (2024) Anticoagulation in Patients with Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices. Current Pharmaceutical Design, 30, 485-488. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Russo, V., Rapacciuolo, A., Rago, A., Tavoletta, V., De Vivo, S., Ammirati, G., et al. (2022) Early Evaluation of Atrial High Rate Episodes Using Remote Monitoring in Pacemaker Patients: Results from the RAPID Study. Journal of Arrhythmia, 38, 213-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Boriani, G., Gerra, L., Mantovani, M., Tartaglia, E., Mei, D.A., Imberti, J.F., et al. (2023) Atrial Cardiomyopathy: An Entity of Emerging Interest in the Clinical Setting. European Journal of Internal Medicine, 118, 14-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Chiuariu, T., Anghel, L., Popa, D.M., Bîrgoan, G., Fechet, Ș.D., Zanfirescu, R., et al. (2026) Predictors for Device-Detected Subclinical Atrial Fibrillation: An Up-To-Date Narrative Review. Journal of Clinical Medicine, 15, Article 578. [Google Scholar] [CrossRef]
|
|
[16]
|
Huang, S.H., Liao, C.F., Chen, Z.Y., Chao, T.F., Chen, S.A. and Tsao, H.M. (2022) Distinct Atrial Remodeling in Patients with Subclinical Atrial Fibrillation: Lessons from Computed Tomographic Images. Pharmacology Research & Perspectives, 10, e00927. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Sharma, G., Ghati, N., Sharique, M., Sharma, S., Shetkar, S., Karmakar, S., et al. (2020) Role of Inflammation in Initiation and Maintenance of Atrial Fibrillation in Rheumatic Mitral Stenosis—An Analytical Cross‐Sectional Study. Journal of Arrhythmia, 36, 1007-1015. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Pamporis, K., Karakasis, P., Sagris, M., Theofilis, P., Milaras, N., Pantelidaki, A., et al. (2025) Prevalence of Asymptomatic Atrial Fibrillation and Risk Factors Associated with Asymptomatic Status: A Systematic Review and Meta-analysis. European Journal of Preventive Cardiology. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Carneiro, H.A. and Knight, B. (2024) Does Asymptomatic Atrial Fibrillation Exist? Journal of Cardiovascular Electrophysiology, 35, 522-529. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Schiavone, M. and Di Biase, L. (2026) Silence Is Not Always Golden: Should We Perform Catheter Ablation in Asymptomatic Atrial Fibrillation? Clinical Debate and Emerging Evidence. Progress in Cardiovascular Diseases, 94, 3-7. [Google Scholar] [CrossRef]
|
|
[21]
|
Karakasis, P., Pamporis, K., Siontis, K.C., Theofilis, P., Samaras, A., Patoulias, D., et al. (2025) Major Clinical Outcomes in Symptomatic vs. Asymptomatic Atrial Fibrillation: A Meta-Analysis. European Heart Journal, 46, 1189-1202. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Boriani, G., Mei, D.A., Vitolo, M. and Imberti, J.F. (2025) The 2024 ESC Guidelines on Atrial Fibrillation: Essential Updates for Everyday Clinical Practice. Internal and Emergency Medicine, 20, 1299-1306. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Diener, H.C., Becher, N., Sehner, S., Toennis, T., Bertaglia, E., Blomstrom‐Lundqvist, C., et al. (2024) Anticoagulation in Patients with Device‐Detected Atrial Fibrillation with and without a Prior Stroke or Transient Ischemic Attack: The NOAH‐AFNET 6 Trial. Journal of the American Heart Association, 13, e036429. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Simu, G.R., Tomoaia, R., Rosu, R.O., Gusetu, G., Puiu, M., Cismaru, G., et al. (2023) Galectin-3, Inflammation, and the Risk of Atrial High-Rate Episodes in Patients with Dual Chamber Pacemakers. International Journal of Molecular Sciences, 24, Article 7710. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Meynet, I., Karvonen, J., Boriani, G., Penela, D., Mazurek, M., Mugnai, G., et al. (2025) Management of Device-Detected Subclinical Atrial Fibrillation: A European Heart Rhythm Association Survey. Europace, 27, euaf284. [Google Scholar] [CrossRef]
|
|
[26]
|
Ramos-Maqueda, J., Arriaga-Jiménez, A., Cabrera-Ramos, M., Vadillo-Martín, P., Meseguer-González, D., Melero-Polo, J., et al. (2026) Reduction in New-Onset Device-Detected Atrial Fibrillation: A Prospective 2-Center Study Comparing Left Bundle Branch Pacing with Conventional Right Ventricular Pacing. Heart Rhythm O2, 7, 487-493. [Google Scholar] [CrossRef]
|
|
[27]
|
Chang, P., Liu, Z., Huang, Y., Chen, J., Chou, C., Wo, H., et al. (2025) Utilizing 12-Lead Electrocardiogram and Machine Learning to Retrospectively Estimate and Prospectively Predict Atrial Fibrillation and Stroke Risk. Computers in Biology and Medicine, 188, Article ID: 109871. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Becher, N., Metzner, A. and Kirchhof, P. (2025) Anticoagulation in Patients with Low-Burden Atrial Fibrillation: New Evidence Focussing on Device-Detected AF. Heart, 111, 999-1003. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Mostafa, M.A., Bodziock, G., Cotten, L., Schaich, C.L., Seiler, A., Dillon, J., et al. (2025) Exploring Optimal Cardiac Electronic Implantable Devices Programming: Reducing Non‐Actionable Alerts and Assessing Clinical Outcomes. Journal of Cardiovascular Electrophysiology, 36, 2226-2232. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Nayak, T., Lohrmann, G. and Passman, R. (2024) Controversies in Diagnosis and Management of Atrial Fibrillation. Cardiology in Review. [Google Scholar] [CrossRef] [PubMed]
|